1. Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatment: A review
   Yuanze Wang et al, 2022, European Journal of Medicinal Chemistry CrossRef
2. Pre-clinical activity of targeting the PI3K/Akt/mTOR pathway in Burkitt lymphoma
   Maria Bhatti et al, 2018, Oncotarget CrossRef
3. Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells
   Xiaosong Shang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
4. Bioinformatics analysis of microRNA expression between patients with and without latent tuberculosis infections
   Yang Lu et al, 2019, Experimental and Therapeutic Medicine CrossRef
5. Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma
   Antonella Bresin et al, 2020, Journal of Investigative Dermatology CrossRef
6. Circular METRN RNA hsa_circ_0037251 Promotes Glioma Progression by Sponging miR-1229-3p and Regulating mTOR Expression
   Qinchen Cao et al, 2019, Scientific Reports CrossRef
7. Pharmacologic characterization of SHR8443, a novel dual inhibitor of phosphatidylinositol 3-kinase and mammalian target of rapamycin
   Chengying Xie et al, 2017, Oncotarget CrossRef
8. Mantle cell lymphoma: insights into therapeutic targets at the preclinical level
   Pavel Klener, 2020, Expert Opinion on Therapeutic Targets CrossRef
9. Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
   Pei Shi Ong et al, 2016, Frontiers in Pharmacology CrossRef
10. Inhibitor PF-04691502 works as a senolytic to regulate cellular senescence
    Ziqiang Fan et al, 2024, Experimental Gerontology CrossRef
11. Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma?
    Chiara Tarantelli et al, 2020, International Journal of Molecular Sciences CrossRef
12. Identification of key gene modules and hub genes of human mantle cell lymphoma by coexpression network analysis
    Dongmei Guo et al, 2020, PeerJ CrossRef
13. Immunological characteristics of Mycobacterium tuberculosis subunit vaccines immunized through different routes
    Yanzhi Lu et al, 2018, Microbial Pathogenesis CrossRef